The global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...
The global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...
The global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to register a compound annual growth rate (CAGR) of 21.7% from 2025 to 2034, driven by the explosive demand for high-purity plasmid DNA (pDNA) as a foundational component in gene therapies, mRNA vaccines, and viral vector production. As the biopharmaceutical industry shifts toward advanced modalities...
The global plasmid DNA manufacturing market, valued at USD 2.38 billion in 2024, is anticipated to expand at a CAGR of 21.7% from 2025 to 2034, with growth increasingly driven by segment-wise performance across scale, end-user applications, and technological platforms. Unlike traditional plasmid production for research, GMP-compliant manufacturing for clinical and commercial use requires...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek